CALGB/SWOG 80405: Phase III Trial of FOLFIRI or FOLFOX with Bevacizumab or Cetuximab for Patients w/KRAS Wild-type Untreated Metastatic Adenocarcinoma of the Colon or Rectum
PANCREOX: A Randomized Phase 3 Study of 5FU/LV with or without Oxaliplatin for 2nd Line Advanced Pancreatic Cancer in Patients Who Have Received Gemcitabine-Based Chemotherapy